INTRODUCTION
The syndrome of severe combined immunodeficiency disease (SCID)1 represents a group of congenital lethal This work was presented in part at the annual meeting ofthe Society for Pediatric Research in Atlanta, Ga., 1979.
Received for publication 11 December 1979 and in revised form 31 March 1980. 'Abbreviations used in this paper: ADA, adenosine deaminase; HTLA, human T lymphocyte antigen; PBM, peripheral blood mononuclear cells; PFC, plaque-forming cells; PWM, pokeweed mitogen; SCID, severe combined immunodisorders, characterized by defects of both B and T cell systems (1) . Proportions ofT lymphocytes in peripheral blood are markedly reduced, but numbers of B lymphocytes are very heterogenous, ranging from complete absence to increased proportions, and even increased absolute numbers. Although B and T lymphocyte function in these patients is grossly deficient in vivo, B cells from some patients have been shown to undergo terminal differentiation in vitro in the presence ofpokeweed mitogen (PWM) and normal T cells (2, 3) . Antigen-specific antibody producing plaque-forming cells have been shown to be generated in peripheral blood mononuclear cells of one patient with SCID after their incubation with thymic epithelial monolayers (4) . This capacity may have reflected induction of helper cell function in the patient's own cells due to exposure of thymic influences. The above observations suggest that in some patients with SCID, circulating B cells may be intrinsically normal, but fail to function in vivo.
In this study, we have examined B and T lymphocyte differentiation responses in peripheral blood as well as in the bone marrow of SCID patients, and have investigated the relationship of B cell differentiation defects with abnormalities of T lymphocyte differentiation in vitro. Our observations suggest that the majority of patients with SCID have abnormalities of both B and T cell lineages. In the group ofpatients with intrinsically "normal" B cells in their circulation, failure of B cell function may be attributed not only to deficiencies of helper T cells but also to an excess of suppressor cells.
antigens or allogeneic cells in the conventional tests. Proportions of B lymphocytes were markedly increased in three patients (B, H, and J). T lymphocytes were decreased in all patients except one (K), who had T cells of maternal origin (determined by sex karyotype) in the circulation. Clinical information on these patients has been recently reported (6) .
Studies described here were performed before any treatment aimed at immunologic reconstitution in all patients except two (B and F). The latter two patients had been given fetal liver transplantation and exhibited donor cell chimerism in peripheral blood, but were without immunologic reconstitution at the time of the present study.
Isolation of cells. Peripheral blood mononuclear cells (PBM) from patients were obtained by centrifugation of -10 ml ofdiluted, heparinized venous blood on sodium metrizoate/ Ficoll cushions (Lymphoprep, Nyegaard and Co., Oslo). Control blood, obtained from healthy laboratory personnel 20-45 yr of age, was separated in a similar manner. For the bone marrow studies, small volumes (0.5-0.7 ml) of marrow were aspirated from several sites on the iliac crest into heparinized glass syringes. Mononuclear cells were first isolated by floatation on metrizoate/Ficoll cushions and then further fractionated by velocity sedimentation at unit gravity (7) . Cells from different fractions were pooled to yield the following cell populations: pool 1 (fractions [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] , consisting largely ofcells ofthe myeloid series; pool 2a (fractions 11-13), consisting mainly of monocytes and a few large lymphocytes; pool 2b (fractions 14-16), containing predominantly medium sized lymphocytes; and pool 3 (fractions [17] [18] [19] [20] [21] [22] [23] [24] , containing mainly small lymphocytes.
T lymphocytes were isolated from normal PBM by rosette formation with neuraminidase-treated sheep erythrocytes (8) and subsequent centrifugation on standard sodium metrizoate/ Ficoll gradients.
Assay for B lymphocyte differentiation. PBM were stimulated in vitro with PWM and subsequently tested for secretion of antibody to sheep erythrocytes in a plaque assay. Culture conditions and assay system were adapted (9) from those described by Fauci (Fig. 1) . Suppression was occasionally noted in cocultures containing cells from patients (19) in anotherassay system. However, the likelihood that suppressor cells can play a role in the immunodeficiency of SCID be- (26, 27) and Gelfand et al. (4, 28) , and such patients might be immunologically reconstituted by treatment with thymus transplantation alone. The majority of the patients, however, have stem cell defects involving the T cell lineage with or without involvement of B cell lineage. In the latter group, engraftment with normal precursors of T cells might be sufficient to allow function of existing host B lymphocytes.
Some patients with SCID have an associated deficiency of the adenosine deaminase enzyme in their lymphocytes and erythrocytes (29) . The exact basis of immunodeficiency in ADA-negative SCID patients is as yet unclear. It has been suggested that absence of ADA results in accumulation oftoxic metabolites which impair lymphocyte differentiation (30) (31) (32) . Addition of ADA to lymphocyte cultures in vitro (33) and enzyme replacement in vivo (20) have reconstituted immune responses in some but not all patients with this form of SCID. In the patient reported here, both ADA and Tx were needed to reconstitute B cell function in vitro. In vivo, the patient failed to respond to enzyme replacement (with erythrocyte transfusions) alone. Treatment with fetal thymus transplantation coupled with enzyme replacement therapy, however, appears to have reconstituted this patient at least partially for both B and T cell functions. Again, it is apparent that SCID with ADA deficiency comprises yet another heterogeneous group.
Reconstitution of B cell function is often difficult in some patients with SCID; treatment with bone marrow or fetal tissue transplantation may result only in T cell reconstitution and these patients either continue to lack B cells or the B cells of host origin persist but do not attain normal function (34) (35) (36) (37) . Insight into problems relating to B cell engraftment may be attained by a clearer understanding of B lymphocyte differentiation, helper function, and suppressor influences operating in this disease. Investigation into putative genetically restricted suppressor cells, and identification of the locus determining such restriction are very much in order.
